Home / Safety / Kimi for pathology

Moonshot AI

How safe is Kimi for pathology?

GDPR profileOur summary of what the provider itself publishes about your data: EU hosting possible, no training on your data for business use, and self-hostable. Caution means a model with a documented issue, such as an investigation by a regulator. How we measure for pathologyCaution

Kimi raises a specific GDPR concern. The parent company is based in Beijing and falls under Chinese security legislation; its privacy policy does not explicitly mention that jurisdiction. No confidential data in the consumer app; self-hosting the open weights is the safe route. Weigh this heavily before deploying it in pathology.

Where does Kimi stand in pathology?

Shared spot 19 of 25 options for pathology (professional tools and general assistants) on the GDPR profile. 7 options, like Kimi, have a Caution profile. Each tile is an option we track for this field; click for the check.

Strong5
Good2
Limited8
Unknown3
Caution7

Stronger or equally strong in pathology

Latest developments

26 July 2026Kimi K3 open weights (27 July): self-hosting avoids China transfer, licence still unclear

On 27 July 2026, Moonshot AI published the full open weights of Kimi K3 (2.8 trillion parameters, 1M-token context) on Hugging Face. Self-hosting on EU infrastructure sidesteps the GDPR data transfer problem of the hosted API (servers in China, no SCCs published). Point of attention: the final licence terms were not yet published at launch (26 July), Kimi K2 carried commercial restrictions above a certain usage scale. Verify the licence before production use. Infrastructure requirement: approx. 1.4 TB of storage, 350–400 GB of GPU memory with MXFP4 quantisation. source

16 July 2026Kimi K3: no opt-out for model training, data processed in China

At the launch of Kimi K3 (16 July 2026), Moonshot AI's privacy policy states that user content may be used for model training and optimisation, with no in-product opt-out. API calls via platform.moonshot.ai are processed on servers in China; an adequacy decision or SCCs are not explicitly documented. For EU organisations: do not enter personal data until Moonshot publishes a GDPR-compliant set-up. Self-hosting on EU infrastructure (open weights available from around 27 July 2026) avoids the transfer problem. source

Questions

How safe is Kimi for pathology?
Kimi has a specific GDPR concern. The parent company is based in Beijing and falls under Chinese security legislation; its privacy policy does not explicitly mention that jurisdiction. Do not share confidential data in the consumer app; self-hosting the open weights is the safe route. Weigh this heavily before deploying it in pathology. There is a specific GDPR concern, read the details on the page.
Does Kimi train on my data?
The international service is provided by Moonshot AI Pte. Ltd. (Singapore); according to the privacy policy, data is stored on servers in Singapore and content may be used to improve the service. The K2 models are open-weight and can be self-hosted.
What should I watch out for with AI in pathology?
You process special category personal data (health) and sometimes data for genetic research. Software for diagnostic use is an in vitro diagnostic medical device: check whether the algorithm is CE-marked under the IVDR for your exact application and tissue type. Many apps are 'research use only'. Choose providers with ISO 27001 and ISO 13485, a data processing agreement and clear data location (EU hosting or on-premise). Also ask whether your slides are used to train models. Under the EU AI Act, medical AI falling under the IVDR is classed as high-risk. Validate every algorithm locally on your own scanner and stains before using it in routine practice.

Source documents

Everything about Kimi Best AI for pathology

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 1 November 2026 · How we check

Every Friday: what changed in AI for pathology

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.